136 related articles for article (PubMed ID: 21336245)
1. Immunosuppression after kidney transplantation.
Kihm LP; Zeier M; Morath C
Minerva Urol Nefrol; 2011 Mar; 63(1):45-57. PubMed ID: 21336245
[TBL] [Abstract][Full Text] [Related]
2. Immune minimization strategies in renal transplantation.
Brar JE; Nader ND
Immunol Invest; 2014; 43(8):807-18. PubMed ID: 25296235
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy after kidney transplantation: current and new strategies.
Metalidis C; Kuypers D
Minerva Urol Nefrol; 2011 Mar; 63(1):1-19. PubMed ID: 21336242
[TBL] [Abstract][Full Text] [Related]
4. Kidney transplantation: the ideal immunosuppression regimen.
Yabu JM; Vincenti F
Adv Chronic Kidney Dis; 2009 Jul; 16(4):226-33. PubMed ID: 19576552
[TBL] [Abstract][Full Text] [Related]
5. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
Helal I; Chan L
Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression minimization in kidney transplantation.
Cantarovich D; Vistoli F; Soulillou JP
Front Biosci; 2008 Jan; 13():1413-32. PubMed ID: 17981639
[TBL] [Abstract][Full Text] [Related]
7. [Immunosuppression for kidney transplant recipients: current strategies].
Alberú J; Urrea EM
Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
[TBL] [Abstract][Full Text] [Related]
8. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
[TBL] [Abstract][Full Text] [Related]
9. The need for minimization strategies: current problems of immunosuppression.
Bamoulid J; Staeck O; Halleck F; Khadzhynov D; Brakemeier S; Dürr M; Budde K
Transpl Int; 2015 Aug; 28(8):891-900. PubMed ID: 25752992
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the immunosuppressive regimen in heart transplantation.
Eisen H; Ross H
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive strategies to improve outcomes of kidney transplantation.
Tang IY; Meier-Kriesche HU; Kaplan B
Semin Nephrol; 2007 Jul; 27(4):377-92. PubMed ID: 17616271
[TBL] [Abstract][Full Text] [Related]
12. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
13. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.
Yang H
Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S37-51. PubMed ID: 16567240
[TBL] [Abstract][Full Text] [Related]
14. Immunological risks of minimization strategies.
Snanoudj R; Tinel C; Legendre C
Transpl Int; 2015 Aug; 28(8):901-10. PubMed ID: 25809144
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor sparing in renal transplantation.
Ekberg H
Transplantation; 2008 Sep; 86(6):761-7. PubMed ID: 18813097
[TBL] [Abstract][Full Text] [Related]
16. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression for lung transplantation.
Bhorade SM; Stern E
Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection.
Krischock L; Gullett A; Bockenhauer D; Rees L; Trompeter RS; Marks SD
Pediatr Transplant; 2009 Jun; 13(4):475-81. PubMed ID: 18992054
[TBL] [Abstract][Full Text] [Related]
19. Daclizumab as induction therapy in kidney and simultaneous pancreas-kidney transplantation.
Ciancio G; Mattiazzi A; Miller J; Burke GW
Minerva Urol Nefrol; 2003 Mar; 55(1):43-56. PubMed ID: 12773966
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of calcineurin inhibitors (CNIs) and steroid avoidance immunosuppressive protocol among living donor kidney transplant recipients.
Oh HK; Ding P; Satmary NA
Yonsei Med J; 2004 Dec; 45(6):1143-8. PubMed ID: 15627310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
